Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Risperidone in Acute Relapse of Schizophrenia
NCT00283179Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, schizoaffective disorder, sponsored by Otsuka Holdings. Started Mar 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00283179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283179.